IMO there is no question another CR will be required. On current sales it will take a while yet for Cardiocel to pay its way and the vaccines generate nothing.... meantime AHZ have baseline fixed costs of at least $15m per annum. Punters talk about $28m but it's already being chewed into and those fixed costs are relentless - so yes there will be another CR at some point, not next month, but it will happen. More shares on issue, more dilution.... it's part of the reason AHZ is not yet an attractive proposition for real investors.
Another CR ?, page-21
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.80 |
Change
-0.200(1.67%) |
Mkt cap ! $249.4M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.99 | $11.63 | $303.4K | 24.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1100 | $11.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 849 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |